Hematopoietic Stem Cell Transplantation Market Trends [2031]

Hematopoietic Stem Cell Transplantation Market Trends [2031]

Segments - Global Hematopoietic Stem Cell Transplantation Market by Transplant Types (Allogeneic and Autologous), Indications (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Other Non-malignant Disorders), Applications (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Cord Blood Transplant), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4242 | 4.3 Rating | 63 Reviews | 176 Pages | Format : PDF Excel PPT

Report Description


The global hematopoietic stem cell transplantations market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Increase in research and patent filings by market participants is expected to drive the market.

Hematopoietic Stem Cell Transplantation Market key takeaways

Hematopoietic stem cell transplantation is a procedure that involves the transplantation of multi-potent hematopoietic stem cells derived from peripheral blood cells, bone marrow, or umbilical cord blood into a patient. Hematopoietic stem cells can develop into mature blood cells such as platelets, white blood cells, and red blood cells. These cells are used to rebuild or replace a patient's hematopoietic system in the treatment of malignant and non-malignant diseases. This is referred to as a stem cell transplant or a bone marrow transplant.

  • Rising prevalence for myeloid leukemia and lymphoma along with the increasing number of the ageing population globally is a key driver expected to propel the market in the coming years.
  • Wide availability of technologically advanced equipment and growing demand for personalized medicine are the primary factors driving the market.
  • Side effects associated with the transplantation on organs and other parts of the body such as the gastrointestinal tract, mouth, heart, and lungs are key challenges expected to impede the market growth during the forecast period.
  • High cost of transplantation and lack of funding from organizations such as the Worldwide Network for Blood and Marrow Transplantation are expected to restrain the market during the forecast period.
  • Ongoing massive R&D programs to develop innovative transplantation devices for stem cells by key players present key growth opportunities of the market in the long run.

Scope of the report

The report on the global hematopoietic stem cell transplantations market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Hematopoietic Stem Cell Transplantation Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Transplant Types (Allogeneic and Autologous), Indications (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Other Non-malignant Disorders), Applications (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Cord Blood Transplant)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market Scope, Analysis, Share, Competitive Analysis, Growth Facts, Restraints, Opportunities, and Revenue Forecast

Key Players Covered

Pluristem Therapeutics Inc.; CellGenix GmbH; RegenBiopharma Inc.; Lonza Group, KiadisPharma; Taiga Biotechnologies, Inc.; Takeda Pharmaceutical Company Limited; Escape Therapeutics, Inc.; Bluebird Bio; and Talaris Therapeutics, Inc.

 

Hematopoietic Stem Cell Transplantations Market Segment Insights

Autologous segment to hold large market share

On the basis of transplant types, the global hematopoietic stem cell transplantation market is bifurcated into allogeneic and autologous. The autologous segment is expected to hold significant share of the global market in the coming years owing to rising number of vendors in the market for the transplant types. A large number of players are likely to concentrate on capturing business opportunities in this segment due to high demand for the types of transplant.

Hematopoietic Stem Cell Transplantation Market by transplant types

Acute myeloid leukemia segment to grow rapidly

In terms of indications, the market is segmented into acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma (MM), and other non-malignant disorders. The AML segment is projected to grow rapidly during the forecast period due to high prevalence of Leukemia as it is a type of cancer that affects the body's blood-forming tissues, bone marrow, and lymphatic system. Moreover, these types of leukemia are common in children.

Bone marrow transplant segment to account for significant market share

Based on applications, the global hematopoietic stem cell transplantation market is segregated into bone marrow transplant (BMT), peripheral blood stem cells transplant (PBCT), and cord blood transplant (CBT). The BMT segment is anticipated to hold major share of the market in the coming years owing to high demand for bone marrow transplant due to rising number of patients suffering from such type of disease globally.

North America to dominate the market

In terms of regions, the market is split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a key share of the global market in 2020 and is likely to dominate the market during the projected period due to the presence of a large number of ageing population as well as widespread prevalence of several chronic illness especially cancer. Moreover, the availability of cutting-edge technology and growing demand for personalized medicine are primary factors driving the market growth in the region.

Hematopoietic Stem Cell Transplantation Market by regions

Segments


By Transplant Types
  • Allogeneic
  • Autologous
By Indications
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)
  • Multiple Myeloma (MM)
  • Other Non-malignant Disorders
By Applications
  • Bone Marrow Transplant (BMT)
  • Peripheral Blood Stem Cells Transplant (PBSCT)
  • Cord Blood Transplant (CBT)
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa
By Key Players
  • Pluristem Therapeutics Inc.
  • CellGenix GmbH
  • RegenBiopharma Inc.
  • Lonza Group
  • KiadisPharma
  • Taiga Biotechnologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Escape Therapeutics, Inc.
  • Bluebird Bio
  • Talaris Therapeutics, Inc.

Competitive Landscape

Key players in the global hematopoietic stem cell transplantations market are Pluristem Therapeutics Inc.; CellGenix GmbH; RegenBiopharma Inc.; Lonza Group, KiadisPharma; Taiga Biotechnologies, Inc.; Takeda Pharmaceutical Company Limited; Escape Therapeutics, Inc.; Bluebird Bio; and Talaris Therapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Hematopoietic Stem Cell Transplantation Market by key players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hematopoietic Stem Cell Transplantation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Hematopoietic Stem Cell Transplantation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Hematopoietic Stem Cell Transplantation Market - Supply Chain
  4.5. Global Hematopoietic Stem Cell Transplantation Market Forecast
     4.5.1. Hematopoietic Stem Cell Transplantation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Hematopoietic Stem Cell Transplantation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Hematopoietic Stem Cell Transplantation Market Absolute $ Opportunity
5. Global Hematopoietic Stem Cell Transplantation Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
6. North America Hematopoietic Stem Cell Transplantation Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
7. Latin America Hematopoietic Stem Cell Transplantation Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
8. Europe Hematopoietic Stem Cell Transplantation Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
9. Asia Pacific Hematopoietic Stem Cell Transplantation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
10. Middle East & Africa Hematopoietic Stem Cell Transplantation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Hematopoietic Stem Cell Transplantation Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Hematopoietic Stem Cell Transplantation Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Hematopoietic Stem Cell Transplantation Market: Market Share Analysis
  11.2. Hematopoietic Stem Cell Transplantation Distributors and Customers
  11.3. Hematopoietic Stem Cell Transplantation Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Pluristem Therapeutics Inc.
     11.4.2. CellGenix GmbH
     11.4.3. RegenBiopharma Inc.
     11.4.4. Lonza Group
     11.4.5. KiadisPharma
     11.4.6. Taiga Biotechnologies, Inc.
     11.4.7. Takeda Pharmaceutical Company Limited

Methodology

Our Clients

Pfizer
Honda Motor Co. Ltd.
Deloitte
Microsoft
General Electric
Nestle SA
Siemens Healthcare
FedEx Logistics